BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6090176)

  • 1. Inhibition of [3H]imipramine binding and [3H]5-HT uptake in human platelets by some natural indoleamine and catecholamine aldehyde condensation products.
    Brusov OS; Fomenko AM; Katasonov AB
    Eur J Pharmacol; 1984 Aug; 103(1-2):191-2. PubMed ID: 6090176
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Methoxytryptoline, a competitive endocoid acting at [3H]imipramine recognition sites in human platelets.
    Segonzac A; Schoemaker H; Tateishi T; Langer SZ
    J Neurochem; 1985 Jul; 45(1):249-56. PubMed ID: 2987413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.
    Langer SZ; Lee CR; Schoemaker H; Segonzac A; Esnaud H
    Prog Clin Biol Res; 1985; 192():441-55. PubMed ID: 3001765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted tetrahydro-beta-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition site.
    Langer SZ; Raisman R; Tahraoui L; Scatton B; Niddam R; Lee CR; Claustre Y
    Eur J Pharmacol; 1984 Feb; 98(1):153-4. PubMed ID: 6325207
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients.
    Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G
    Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.
    Poirier MF; Galzin AM; Loo H; Pimoule C; Segonzac A; Benkelfat C; Sechter D; Zarifian E; Schoemaker H; Langer SZ
    Biol Psychiatry; 1987 Mar; 22(3):287-302. PubMed ID: 3028514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets.
    Airaksinen MM; Svensk H; Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):308-13. PubMed ID: 7368950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible endocrine role of the pineal gland for 6-methoxytetrahydro-beta-carboline, a putative endogenous neuromodulator of the [3H]imipramine recognition site.
    Langer SZ; Lee CR; Segonzac A; Tateishi T; Esnaud H; Schoemaker H; Winblad B
    Eur J Pharmacol; 1984 Jul; 102(2):379-80. PubMed ID: 6090167
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet 3H-imipramine binding, serotonin uptake, and plasma alpha 1 acid glycoprotein in disruptive behavior disorders.
    Stoff DM; Ieni J; Friedman E; Bridger WH; Pollock L; Vitiello B
    Biol Psychiatry; 1991 Mar; 29(5):494-8. PubMed ID: 1708290
    [No Abstract]   [Full Text] [Related]  

  • 11. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.
    Poirier MF; Loo H; Benkelfat C; Sechter D; Zarifian E; Galzin AM; Schoemaker H; Segonzac A; Langer SZ
    Eur J Pharmacol; 1984 Nov; 106(3):629-33. PubMed ID: 6097464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization and assay of [3H]imipramine binding sites from human platelets.
    Davis A; Morris J; Tang SW
    Eur J Pharmacol; 1983 Jan; 86(3-4):353-9. PubMed ID: 6299755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
    Weizman A; Carmi M; Hermesh H; Shahar A; Apter A; Tyano S; Rehavi M
    Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization and partial purification of the high affinity [3H] imipramine binding site from human platelets.
    Rehavi M; Skolnick P; Paul SM
    FEBS Lett; 1982 Dec; 150(2):514-8. PubMed ID: 6297983
    [No Abstract]   [Full Text] [Related]  

  • 17. [3H]imipramine displacement and 5HT uptake inhibition by tryptoline derivatives: in rat brain 5-methoxytryptoline is not the autacoid for [3H]imipramine recognition sites.
    Barbaccia ML; Melloni P; Pozzi O; Costa E
    Eur J Pharmacol; 1986 Apr; 123(1):45-52. PubMed ID: 3011457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Problems of drug recognition. Imipramine receptors].
    ShimanovskiÄ­ NL; Sergeev PV
    Farmakol Toksikol; 1986; 49(1):103-7. PubMed ID: 3005029
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific high affinity [3H]imipramine binding sites in rat lung are associated with a non-neuronal uptake site for serotonin.
    Raisman R; Langer SZ
    Eur J Pharmacol; 1983 Oct; 94(3-4):345-8. PubMed ID: 6317406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two distinctive beta-carbolines on serotonin binding in human platelets.
    Taylor DL; Tansey W; Cook JM; Ho BT
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):133-6. PubMed ID: 3983465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.